Free Trial

FOXO Technologies Q2 2024 Earnings Report

FOXO Technologies logo
$0.28 -0.01 (-4.42%)
(As of 12/20/2024 05:31 PM ET)

FOXO Technologies Earnings Headlines

FOXO Technologies regains NYSE compliance, ends indicator
The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
FOXO Technologies Regains NYSE Compliance with Equity Boost
FOXO Technologies Strengthens Financials and Leadership
See More FOXO Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FOXO Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FOXO Technologies and other key companies, straight to your email.

About FOXO Technologies

FOXO Technologies (NYSEAMERICAN:FOXO) engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

View FOXO Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings